Weighted Average Number of Shares Outstanding, Basic of AGIOS PHARMACEUTICALS, INC. from 30 Sep 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
AGIOS PHARMACEUTICALS, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Sep 2013 to 31 Dec 2025.
  • AGIOS PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 57,972,004, a 2% increase year-over-year.
  • AGIOS PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 57,972,004, a 2% increase from 2024.
  • AGIOS PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 56,807,415, a 2.1% increase from 2023.
  • AGIOS PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 55,651,487, a 1.6% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

AGIOS PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 57,972,004 +1,164,589 +2% 01 Oct 2025 31 Dec 2025 10-K 12 Feb 2026 2025 FY
Q3 2025 58,139,277 +1,199,874 +2.1% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 57,932,576 +1,130,030 +2% 01 Apr 2025 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 57,459,195 +1,075,720 +1.9% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 56,807,415 +1,155,928 +2.1% 01 Oct 2024 31 Dec 2024 10-K 12 Feb 2026 2025 FY
Q3 2024 56,939,403 +1,135,740 +2% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025 2025 Q3
Q2 2024 56,802,546 +1,198,216 +2.2% 01 Apr 2024 30 Jun 2024 10-Q 31 Jul 2025 2025 Q2
Q1 2024 56,383,475 +1,118,085 +2% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 55,651,487 +862,052 +1.6% 01 Oct 2023 31 Dec 2023 10-K 12 Feb 2026 2025 FY
Q3 2023 55,803,663 +959,084 +1.7% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 55,604,330 +804,650 +1.5% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024 2024 Q2
Q1 2023 55,265,390 +709,923 +1.3% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 54,789,435 -5,657,911 -9.4% 01 Oct 2022 31 Dec 2022 10-K 13 Feb 2025 2024 FY
Q3 2022 54,844,579 -2,203,596 -3.9% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 54,799,680 -6,267,297 -10% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 54,555,467 -14,988,043 -22% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 60,447,346 -8,550,533 -12% 01 Oct 2021 31 Dec 2021 10-K 15 Feb 2024 2023 FY
Q3 2021 57,048,175 -12,095,886 -17% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 61,066,977 -7,891,114 -11% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 69,543,510 +935,231 +1.4% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 68,997,879 01 Oct 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
Q3 2020 69,144,061 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 68,958,091 01 Apr 2020 30 Jun 2020 10-Q 29 Jul 2021 2021 Q2
Q1 2020 68,608,279 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021 2021 Q1
Q3 2015 37,507,298 +3,012,222 +8.7% 01 Jul 2015 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q3 2014 34,495,076 +11,750,590 +52% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015 2015 Q3
Q3 2013 22,744,486 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2014 Q3

AGIOS PHARMACEUTICALS, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 57,972,004 +1,164,589 +2% 01 Jan 2025 31 Dec 2025 10-K 12 Feb 2026 2025 FY
2024 56,807,415 +1,155,928 +2.1% 01 Jan 2024 31 Dec 2024 10-K 12 Feb 2026 2025 FY
2023 55,651,487 +862,052 +1.6% 01 Jan 2023 31 Dec 2023 10-K 12 Feb 2026 2025 FY
2022 54,789,435 -5,657,911 -9.4% 01 Jan 2022 31 Dec 2022 10-K 13 Feb 2025 2024 FY
2021 60,447,346 -8,550,533 -12% 01 Jan 2021 31 Dec 2021 10-K 15 Feb 2024 2023 FY
2020 68,997,879 +9,003,340 +15% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 59,994,539 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.